Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

1.6K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.6K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

1.4K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.4K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Invited Commentary on:</i> Lu et al.'s "Functional and Aesthetic Considerations for Selective Facial Neurectomy with Simultaneous Deep Plane Facelift and Structural Neck Contouring for Facial Paralysis with Synkinesis".

Facial plastic surgery & aesthetic medicine·2026
Same author

Impact of Achilles tendon rupture on performance and career outcomes in NFL players: a matched cohort study.

The Physician and sportsmedicine·2026
Same author

CLO26-130: Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Pancreatic Ductal Adenocarcinoma With Isolated Peritoneal Metastases: A Meta Analysis and Systematic Review.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

HSR26-233: Socioeconomic Determinants of Treatment Delay in Non Small Cell Lung Cancer at a Community Cancer Program in Southeast Texas.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Collagen-Enriched Immunomodulatory Hydrogel for Tendon Regeneration.

Gels (Basel, Switzerland)·2026
Same author

CGE26-141: Circulating Tumor DNA as a Prognostic Biomarker Across Postoperative, Post-Adjuvant, and Surveillance Windows in Localized Colorectal Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Related Experiment Video

Updated: Apr 16, 2026

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
19:53

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer

Published on: March 1, 2015

106.7K

Review of Treatment Options for Facial Synkinesis: Working Toward a Standardized Algorithm.

Aileen Z Cui1, Shivam Patel2, Dana Smithnosky3

  • 1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|April 14, 2026
PubMed
Summary

Facial synkinesis, a condition from facial nerve injury, has many treatments but lacks a clear care sequence. This review proposes an algorithm to guide management for better patient outcomes.

Keywords:
AlgorithmBell's palsyFacial paralysisSynkinesis

More Related Videos

Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration
05:04

Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration

Published on: May 5, 2020

8.3K
An Implantable System For Chronic In Vivo Electromyography
09:52

An Implantable System For Chronic In Vivo Electromyography

Published on: April 21, 2020

11.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
19:53

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer

Published on: March 1, 2015

106.7K
Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration
05:04

Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration

Published on: May 5, 2020

8.3K
An Implantable System For Chronic In Vivo Electromyography
09:52

An Implantable System For Chronic In Vivo Electromyography

Published on: April 21, 2020

11.5K

Area of Science:

  • Neurology
  • Ophthalmology
  • Plastic Surgery

Background:

  • Facial synkinesis results from facial nerve injury, often seen after Bell's palsy or trauma.
  • Characterized by muscle hypertonicity, involuntary co-contraction, and spasms, it causes significant functional and aesthetic issues.
  • While not curable, current treatment lacks consensus on optimal timing and sequencing.

Purpose of the Study:

  • To review current treatment trends for facial synkinesis.
  • To propose a management algorithm integrating current practices and individualized decision-making.
  • To provide a framework for managing patients with facial synkinesis.

Main Methods:

  • Literature review of current treatment modalities for facial synkinesis.
  • Analysis of non-invasive (physical therapy, botulinum toxin) and invasive (myectomy, neurectomy) options.
  • Development of a treatment algorithm based on clinical presentation and patient factors.

Main Results:

  • Facial synkinesis management is complex due to diverse treatment options and lack of consensus.
  • Optimal strategies depend on patient preference, clinical presentation, and provider expertise.
  • An algorithmic approach can help standardize and individualize care.

Conclusions:

  • A structured, algorithmic approach can aid in the evaluation and management of facial synkinesis.
  • Individualized decision-making is crucial for optimizing treatment outcomes.
  • Further consensus on treatment sequencing is needed to refine patient care pathways.